No Data
No Data
No Data
Bernstein starts to focus on US pharmaceutical stocks, giving Eli Lilly and Co (LLY.US) and others a "outperforming the large cap" rating.
Bernstein starts covering Eli Lilly and Co (LLY.US), Gilead Sciences (GILD.US), and Amgen (AMGN.US), all with an "outperform" rating.
Lilly, Gilead, Amgen Started at Outperform by Bernstein
Precision AQ Appoints Lance Grady as Executive Vice President, Managing Partner, Consulting Solutions
Jim Cramer on Bristol-Myers Squibb Company (BMY): 'I Think It's A Great Time To Consider Buying This One'
After eight weeks of selling off, the hedge fund bought back US stocks, achieving the fastest speed since 2021.
The US stock market is currently experiencing active buying and market growth, but the market's high valuation is a concerning issue that may trigger future adjustments.
The Zacks Analyst Blog Highlights Bristol-Myers Squibb, Arthur J. Gallagher, TC Energy and Bridger Aerospace
No Data
No Data
103811615 : Nyi Nyi Htwe Y324412